P Durando

Summary

Affiliation: University of Genoa
Country: Italy

Publications

  1. pmc Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen
    G Icardi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Clin Microbiol 39:3110-4. 2001
  2. pmc Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study
    Paolo Durando
    Department of Health Sciences, Associate Professor of Hygiene, Preventive Medicine and Public Health, Hygiene Unit, IRCCS AOU San Martino IST teaching Hospital, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy
    BMC Infect Dis 13:443. 2013
  3. doi request reprint Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery
    Paolo Durando
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Am J Infect Control 40:969-72. 2012
  4. doi request reprint Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy
    Paolo Durando
    Department of Health Sciences, San Martino Hospital, University of Genoa, Via A Pastore 1, 16132 Genoa, Italy
    Vaccine 27:3459-62. 2009
  5. ncbi request reprint Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence study
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa and San Martino University Hospital of Genoa, Italy
    J Prev Med Hyg 51:80-6. 2010
  6. ncbi request reprint Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
    Paolo Durando
    Vaccines and Clinical Trials Unit, Department of Health Sciences, University of Genoa, Genoa, Italy
    Hum Vaccin 7:29-40. 2011
  7. doi request reprint Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa and San Martino University Hospital of Genoa, Italy
    J Hosp Infect 71:81-7. 2009
  8. pmc Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults
    P Durando
    Department of Health Sciences, University of Genoa, 16132 Genoa, Italy
    Clin Vaccine Immunol 15:253-9. 2008
  9. ncbi request reprint Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, San Martino Hospital, University of Genoa, Genoa, Italy
    Euro Surveill 12:E070607.1. 2007
  10. ncbi request reprint Public health research literature on infectious diseases: coverage and gaps in Europe
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, San Martino Hospital, University of Genoa, Genoa, Italy
    Eur J Public Health 17:19-23. 2007

Detail Information

Publications35

  1. pmc Novel approach to reduce the hepatitis C virus (HCV) window period: clinical evaluation of a new enzyme-linked immunosorbent assay for HCV core antigen
    G Icardi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Clin Microbiol 39:3110-4. 2001
    ..In conclusion, the HCV antigen assay showed high sensitivity and specificity and could become a useful means of improving the safety of blood and blood products...
  2. pmc Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study
    Paolo Durando
    Department of Health Sciences, Associate Professor of Hygiene, Preventive Medicine and Public Health, Hygiene Unit, IRCCS AOU San Martino IST teaching Hospital, University of Genoa, Via Antonio Pastore 1, 16132, Genoa, Italy
    BMC Infect Dis 13:443. 2013
    ..The aim of the study was to estimate the prevalence of LTBI and evaluate the main risk-factors associated with this condition in a cohort of healthcare Italian students...
  3. doi request reprint Adherence to international and national recommendations for the prevention of surgical site infections in Italy: results from an observational prospective study in elective surgery
    Paolo Durando
    Department of Health Sciences, University of Genoa, Genoa, Italy
    Am J Infect Control 40:969-72. 2012
    ....
  4. doi request reprint Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy
    Paolo Durando
    Department of Health Sciences, San Martino Hospital, University of Genoa, Via A Pastore 1, 16132 Genoa, Italy
    Vaccine 27:3459-62. 2009
    ..2%, 70.5% and 36.4%, respectively...
  5. ncbi request reprint Hospital-acquired infections and leading pathogens detected in a regional university adult acute-care hospital in Genoa, Liguria, Italy: results from a prevalence study
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa and San Martino University Hospital of Genoa, Italy
    J Prev Med Hyg 51:80-6. 2010
    ....
  6. ncbi request reprint Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine
    Paolo Durando
    Vaccines and Clinical Trials Unit, Department of Health Sciences, University of Genoa, Genoa, Italy
    Hum Vaccin 7:29-40. 2011
    ....
  7. doi request reprint Surveillance of hospital-acquired infections in Liguria, Italy: results from a regional prevalence study in adult and paediatric acute-care hospitals
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, University of Genoa and San Martino University Hospital of Genoa, Italy
    J Hosp Infect 71:81-7. 2009
    ..Our study provides an overall picture of the epidemiology of HAI in Liguria, which may be usefully employed as a starting point to plan and organise future surveillance and control programmes...
  8. pmc Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults
    P Durando
    Department of Health Sciences, University of Genoa, 16132 Genoa, Italy
    Clin Vaccine Immunol 15:253-9. 2008
    ..The results showed good safety and immunogenicity for both vaccines under study for both uninfected and HIV-1-infected adults, confirming current recommendations for immunization of this high-risk category...
  9. ncbi request reprint Ostreopsis ovata and human health: epidemiological and clinical features of respiratory syndrome outbreaks from a two-year syndromic surveillance, 2005-06, in north-west Italy
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, San Martino Hospital, University of Genoa, Genoa, Italy
    Euro Surveill 12:E070607.1. 2007
  10. ncbi request reprint Public health research literature on infectious diseases: coverage and gaps in Europe
    P Durando
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, San Martino Hospital, University of Genoa, Genoa, Italy
    Eur J Public Health 17:19-23. 2007
    ..The aim was to gain an overall view of published research on IDs in Europe as part of the collaborative study SPHERE (Strengthening Public Health Research in Europe)...
  11. doi request reprint MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk
    Paolo Durando
    Department of Health Sciences Section of Hygiene and Preventive Medicine, University of Genoa, Head of the Outpatient Clinic of the Hygiene Unit, San Martino University Hospital, Via Pastore 1 16132, Genoa, Italy
    Expert Opin Biol Ther 10:639-51. 2010
    ..The protection offered by non-adjuvanted vaccines may be further reduced by periodic antigenic drifts...
  12. ncbi request reprint Bacterial carriage and respiratory tract infections in subjects > or = 60 years during an influenza season: implications for the epidemiology of community acquired pneumonia and influenza vaccine effectiveness
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 53:94-7. 2012
    ....
  13. ncbi request reprint Molecular epidemiology and case-control approaches for management of an outbreak of hepatitis A in Liguria, Italy
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 48:103-8. 2007
    ....
  14. ncbi request reprint Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy
    F Ansaldi
    Department of Health Sciences, University of Genoa, Italy
    J Int Med Res 36:1255-60. 2008
    ..2% for all cause pneumonia to 70.5% for pneumococcal pneumonia. This study contributes to the growing body of information that supports the beneficial effect of PCV7 vaccination...
  15. ncbi request reprint Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains
    R Gasparini
    Interuniversity Centre for Research on Influenza and Viral Infections CIRI IV, Department of Health Sciences, University of Genoa, Italy
    Eur J Clin Microbiol Infect Dis 26:619-28. 2007
    ..A/H3N2 strains belonged to two clusters, A/Panama/2007/99-like and A/Fujian/411/02-like, a new variant. This paper discusses the possible role of the identified flu strains in determining EUARs among the population by age class...
  16. doi request reprint Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation
    F Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Hosp Infect 79:134-40. 2011
    ..A molecular approach allowed the prompt introduction of infection control measures and the evaluation of data in a global epidemiological context...
  17. ncbi request reprint Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study
    F Ansaldi
    Department of Health Sciences, University of Genoa, Genoa, Italy
    J Int Med Res 33:490-500. 2005
    ....
  18. ncbi request reprint Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine
    P Durando
    Vaccines and Clinical Trials Unit, Department of Health Sciences, University of Genoa, Genoa, Italy
    J Prev Med Hyg 53:68-77. 2012
    ..The most interesting results from clinical trials using PCV13 in both children and adults are reported and discussed in details...
  19. ncbi request reprint Impact of influenza during the post-pandemic season: epidemiological picture from syndromic and virological surveillance
    D de Florentiis
    CIRI IV, Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 52:134-6. 2011
    ..We described the epidemiological picture emerged from syndromic and virological surveillance during the post-pandemic season in Liguria, Italy...
  20. ncbi request reprint MF-59 adjuvant influence on the functions of gammadelta T cells in HIV-1+ adults immunized with influenza seasonal vaccine
    D Fenoglio
    Clinic Immunology Unit, CEBR, University of Genoa, Italy
    J Prev Med Hyg 52:137-41. 2011
    ....
  21. ncbi request reprint Experience with pneumococcal polysaccharide conjugate vaccine (conjugated to CRM197 carrier protein) in children and adults
    P Durando
    Vaccines and Clinical Trial Unit, Department of Health Sciences, University of Genoa and IRCCS AOU San Martino IST of Genoa, Genoa, Italy
    Clin Microbiol Infect 19:1-9. 2013
    ..Novel immunization strategies remain the only practical means to reduce significantly the remaining global mortality and morbidity due to S. pneumoniae in adults...
  22. ncbi request reprint Pneumococcal vaccination in adults: rationale, state of the art and perspectives
    G Icardi
    Department of Health Sciences, Section of Hygiene and Preventive Medicine, Vaccines and Clinical Trials Unit, San Martino Hospital, University of Genoa, Italy
    J Prev Med Hyg 53:78-84. 2012
    ....
  23. ncbi request reprint Pneumococcal vaccination strategies in adult population: perspectives with the pneumococcal 13 - valent polysaccharide conjugate vaccine
    C Alicino
    Department of Health Sciences University of Genoa, Genoa, Italy
    Minerva Med 105:89-97. 2014
    ..The availability of PCV13 for adults offer a new and promising tool against Sp IPDs and non-IPDs, especially in elderly and at risk populations...
  24. ncbi request reprint Role of congenital rubella reference laboratory: 21-months-surveillance in Liguria, Italy
    P Canepa
    Doctoral School in Clinical and Experimental Medicine, University of Genoa, Italy
    J Prev Med Hyg 50:221-6. 2009
    ..Since June 2006, Liguria Administrative Region recognized U.O. Hygiene, "San Martino" University Hospital, Genoa, as regional reference laboratory for diagnosis of rubella infection during pregnancy and post-partum...
  25. ncbi request reprint Evaluation of microbial contamination of air in two haematology departments equipped with ventilation systems with different filtration devices
    P Crimi
    Department of Health Sciences, San Martino Hospital, University of Genoa, Italy
    J Prev Med Hyg 50:33-6. 2009
    ..In this study, we evaluated microbial contamination of the air in two divisions with high risk patients, focusing on the validity of the air system with correlation to the presence or not of the HEPA absolute filters...
  26. ncbi request reprint Performance testing of two new one-step real time PCR assays for detection of human influenza and avian influenza viruses isolated in humans and respiratory syncytial virus
    L Valle
    CIRI IV, Department of Health Sciences, University of Genoa, Italy
    J Prev Med Hyg 47:127-33. 2006
    ..Specificity, analytical and clinical sensitivity, dynamic range, linearity of the new assays were evaluated...
  27. ncbi request reprint Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria
    R Gasparini
    Section of Hygiene and Preventive Medicine, Department of Health Sciences, University of Genoa, Via Pastore 1, 16132 Genova, Italy
    Vaccine 20:B50-4. 2002
    ..We were also able to establish that the vaccine coverage among elderly individuals was 63%. Our study, though carried out during a low epidemic year, confirms the economic advantage of vaccination in the elderly...
  28. ncbi request reprint [Vaccinations for adults at risk and the elderly]
    G Icardi
    Dipartimento di Scienze della Salute, Sezione Igiene e Medicina Preventiva, Universita degli Studi di Genova
    Ann Ig 14:51-8. 2002
  29. ncbi request reprint The dangerous synergism between influenza and Streptococcus pneumoniae and innovative perspectives of vaccine prevention
    C Alicino
    Department of Health Sciences, University of Genoa, San Martino University Hospital of Genoa, Italy
    J Prev Med Hyg 52:102-6. 2011
    ..e. PCV13) offers promising perspectives, to improve the control of influenza through the protection offered against its major complications, particularly CAP, not only in children, but also among adults...
  30. ncbi request reprint Prospective evaluation of a prevention protocol for lymphedema following surgery for breast cancer
    F M Boccardo
    Department of Surgery, Unit of Lymphatic Surgery and Microsurgery, S Martino Hospital, University of Genoa, Italy
    Lymphology 42:1-9. 2009
    ..These prophylactic strategies appear to reduce the development of secondary lymphedema and alter its progression in comparison to the CG women...
  31. ncbi request reprint Safety and immunogenicity of conventional subunit and MF59-adjuvanted influenza vaccines in human immunodeficiency virus-1-seropositive patients
    G Gabutti
    Laboratory of Hygiene, Department of Biological and Environmental Sciences and Technologies, Faculty of Sciences, University of Lecce, Lecce, Italy
    J Int Med Res 33:406-16. 2005
    ..These results confirmed the safety and immunogenicity of these currently available vaccines in HIV-1-seropositive patients, thus supporting the recommendation for influenza immunization in this high-risk category...
  32. ncbi request reprint Immunogenicity and tolerability of a trivalent virosomal influenza vaccine in a cohort of HIV-infected children
    G V Zuccotti
    Department of Paediatrics, San Paolo Hospital, University of Milan, Italy
    J Int Med Res 32:492-9. 2004
    ..9 versus 13.5; A/H1N1: 24.7 versus 5.8; B: 34.4 versus 9.1). No significant changes were observed in either HIV viral load or CD4 cell count following vaccination. Vaccination was well tolerated with only a few mild, transient symptoms...
  33. doi request reprint Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections
    M Bassetti
    Infectious Disease Division, San Martino Hospital and University of Genoa School of Medicine, Genova, Italy
    J Antimicrob Chemother 61:417-20. 2008
    ..We describe the clinical and microbiological outcomes of patients infected with multidrug-resistant Acinetobacter baumannii who were treated with a combination of colistin and rifampicin...
  34. pmc Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy
    G Gabutti
    Department of Clinical and Experimental Medicine, University of Ferrara, Ferrara, Italy
    Epidemiol Infect 136:1576-84. 2008
    ..Nevertheless, over the last 10 years, large increases in vaccination coverage rates have contributed to reduce the spread of the aetiological agent, especially in the immunized population...
  35. ncbi request reprint [Influenza vaccination: advantages of new generation carriers]
    B Bruzzone
    Istituto di Igiene e Medicina Preventiva, Dipartimento di Scienze della Salute, Universita degli Studi di Genova
    Ann Ig 14:11-8. 2002